Table 3.

Adoptively Transferred IL-2−/− T Cells Do Not Adversely Affect the Cellularity or Composition of Host Bone Marow

Donor T Cells Cell No. × 106*% of Mac-1+%GR-1+
Total Thy1.1 (host)Thy1.2 (donor) B220 Ter-119 Mac-1 Gr-1Mac-1loMac-1hiGr-1loGr-1hi
SPF IL-2+/+ 18.1 ± 3.1 0.22 ± 0.1  0.7 ± 0.2  4.6 ± 1.1 7.0 ± 2.1  10.1 ± 2.3  7.0 ± 1.8  40 ± 5 45 ± 7  21 ± 5  26 ± 4  
SPF IL-2−/− 19.8 ± 4.4  0.20 ± 0.2 0.5 ± 0.2  3.9 ± 1.0  6.2 ± 2.4  9.0 ± 2.5  6.0 ± 1.9  37 ± 6  41 ± 8 17 ± 9  23 ± 5 
Donor T Cells Cell No. × 106*% of Mac-1+%GR-1+
Total Thy1.1 (host)Thy1.2 (donor) B220 Ter-119 Mac-1 Gr-1Mac-1loMac-1hiGr-1loGr-1hi
SPF IL-2+/+ 18.1 ± 3.1 0.22 ± 0.1  0.7 ± 0.2  4.6 ± 1.1 7.0 ± 2.1  10.1 ± 2.3  7.0 ± 1.8  40 ± 5 45 ± 7  21 ± 5  26 ± 4  
SPF IL-2−/− 19.8 ± 4.4  0.20 ± 0.2 0.5 ± 0.2  3.9 ± 1.0  6.2 ± 2.4  9.0 ± 2.5  6.0 ± 1.9  37 ± 6  41 ± 8 17 ± 9  23 ± 5 

*Bone marrow was analyzed 6 weeks after adoptive transfer of T cells.

or Create an Account

Close Modal
Close Modal